Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration.
Jiamsakul A, Kariminia A, Althoff KN, Cesar C, Cortes CP, Davies MA, Do VC, Eley B, Gill J, Kumarasamy N, Machado DM, Moore R, Prozesky H, Zaniewski E, Law M. Jiamsakul A, et al. Among authors: machado dm. J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):319-329. doi: 10.1097/QAI.0000000000001499. J Acquir Immune Defic Syndr. 2017. PMID: 28708808 Free PMC article.
Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
Oliveira R, Krauss M, Essama-Bibi S, Hofer C, Robert Harris D, Tiraboschi A, de Souza R, Marques H, Succi R, Abreu T, Della Negra M, Hazra R, Mofenson LM, Siberry GK; NISDI Pediatric Study Group 2010. Oliveira R, et al. Clin Infect Dis. 2010 Dec 1;51(11):1325-33. doi: 10.1086/657119. Epub 2010 Nov 1. Clin Infect Dis. 2010. PMID: 21039218 Free PMC article.
Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy.
Siberry GK, Harris DR, Oliveira RH, Krauss MR, Hofer CB, Tiraboschi AA, Marques H, Succi RC, Abreu T, Della Negra M, Mofenson LM, Hazra R; NISDI PLACES Protocol. Siberry GK, et al. J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):214-8. doi: 10.1097/QAI.0b013e31824e4da6. J Acquir Immune Defic Syndr. 2012. PMID: 22343177 Free PMC article.
Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America.
Duarte HA, Harris DR, Tassiopoulos K, Leister E, Negrini SF, Ferreira FF, Cruz ML, Pinto J, Allison S, Hazra R; NISDI PLACES Study Group. Duarte HA, et al. Braz J Infect Dis. 2015 May-Jun;19(3):263-71. doi: 10.1016/j.bjid.2015.01.004. Epub 2015 Mar 3. Braz J Infect Dis. 2015. PMID: 25743569 Free PMC article.
Implementation of "Treat-all" at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey.
Brazier E, Maruri F, Duda SN, Tymejczyk O, Wester CW, Somi G, Ross J, Freeman A, Cornell M, Poda A, Musick BS, Zhang F, Althoff KN, Mugglin C, Kimmel AD, Yotebieng M, Nash D; IeDEA Consortium. Brazier E, et al. J Int AIDS Soc. 2019 Jul;22(7):e25331. doi: 10.1002/jia2.25331. J Int AIDS Soc. 2019. PMID: 31623428 Free PMC article.
Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study.
Romo ML, Patel RC, Edwards JK, Humphrey JM, Musick BS, Bernard C, Maina MW, Brazier E, Castelnuovo B, Penner J, Wyka K, Cardoso SW, Ly PS, Kunzekwenyika C, Cortés CP, Panczak R, Kelvin EA, Wools-Kaloustian KK, Nash D; International epidemiology Databases to Evaluate AIDS (IeDEA). Romo ML, et al. Ann Intern Med. 2022 Jan;175(1):84-94. doi: 10.7326/M21-3037. Epub 2021 Nov 30. Ann Intern Med. 2022. PMID: 34843382 Free PMC article.
95 results